Jacobio Pharmaceuticals Group Co Ltd banner

Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167

Watchlist Manager
Jacobio Pharmaceuticals Group Co Ltd Logo
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Watchlist
Price: 7.2 HKD -1.37% Market Closed
Market Cap: HK$5.7B

Wall Street
Price Targets

Price Targets Summary
Jacobio Pharmaceuticals Group Co Ltd

Wall Street analysts forecast Jacobio Pharmaceuticals Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jacobio Pharmaceuticals Group Co Ltd is 9.93 HKD with a low forecast of 9.23 HKD and a high forecast of 10.86 HKD.

Lowest
Price Target
9.23 HKD
28% Upside
Average
Price Target
9.93 HKD
38% Upside
Highest
Price Target
10.86 HKD
51% Upside
Jacobio Pharmaceuticals Group Co Ltd Competitors:
Price Targets
VRNS
Varonis Systems Inc
55% Upside
NSIT
Insight Enterprises Inc
58% Upside
MEDP
Medpace Holdings Inc
0% Upside
TTD
Trade Desk Inc
62% Upside

Revenue
Forecast

N/A
Past Growth
126% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
126% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

The compound annual growth rate of Jacobio Pharmaceuticals Group Co Ltd's revenue for the next 2 years is 126%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Jacobio Pharmaceuticals Group Co Ltd's stock price target?
Price Target
9.93 HKD

According to Wall Street analysts, the average 1-year price target for Jacobio Pharmaceuticals Group Co Ltd is 9.93 HKD with a low forecast of 9.23 HKD and a high forecast of 10.86 HKD.

What is Jacobio Pharmaceuticals Group Co Ltd's Revenue forecast?
Projected CAGR
126%

The compound annual growth rate of Jacobio Pharmaceuticals Group Co Ltd's revenue for the next 2 years is 126%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett